Dow Jones

39 935,07

0,20%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Bionik Laboratories Corporation (CE) (BNKL)
Bionik Laboratories Corporation (CE) (BNKL) Actualités

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:BNKL

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
30/06/2023	22h31	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/06/2023	23h05	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/06/2023	16h59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/06/2023	14h56	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
08/02/2023	14h02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/12/2022	17h29	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/12/2022	17h27	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
04/11/2022	21h32	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
25/10/2022	17h28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
27/05/2022	19h31	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
01/06/2020	20h17	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
21/02/2020	23h12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
13/02/2020	18h17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
13/11/2019	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
12/11/2019	21h58	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
28/10/2019	15h05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/09/2019	23h26	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
18/03/2019	11h05	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
11/02/2019	22h21	Edgar (US Regulatory)	Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...	USOTC:BNKL	Bionik Laboratories Corporation (CE)
16/10/2018	23h24	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
17/08/2018	23h15	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
10/08/2018	23h11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
07/08/2018	23h36	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
15/06/2018	20h38	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
05/10/2017	23h27	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
05/10/2017	20h30	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
03/08/2017	23h29	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
14/07/2017	23h29	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
12/07/2017	22h27	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:BNKL	Bionik Laboratories Corporation (CE)
30/06/2017	23h08	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	USOTC:BNKL	Bionik Laboratories Corporation (CE)